Castle Biosciences, Inc.: New Data Confirms Performance of DecisionDx-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...

Stora Enso initiates a strategic review of its Central European sawmills and building solutions operations (Inside information)

Stora Enso is initiating a strategic review of its Central European sawmills and building solutions operations. The review, to be carried out in 2026, will cover one business unit of Wood Products ...

Nagarro releases Q3 2025 results with 9.4% YoY revenue growth in constant currency and 27.2% YoY increase in Adjusted EBITDA; announces share redemption and buyb…

Nagarro, a global digital engineering leader, today presented its unaudited financial numbers for Q3 2025 and released its ...